In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Licostrata Drug Master File in Korea (Licostrata KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Licostrata. The MFDS reviews the Licostrata KDMF as part of the drug registration process and uses the information provided in the Licostrata KDMF to evaluate the safety and efficacy of the drug.
After submitting a Licostrata KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Licostrata API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Licostrata suppliers with KDMF on PharmaCompass.